Showing 1 - 9 results of 9 for search 'Bart van Hoek', query time: 0.43s
Refine Results
-
1
-
2
Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis by Sofia Karkampouna, Danny van der Helm, Mario Scarpa, Bart van Hoek, Hein W. Verspaget, Marie-Jose Goumans, Minneke J. Coenraad, Boudewijn P.T. Kruithof, Marianna Kruithof-de Julio
Published 2021-11-01
Article -
3
Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt by Maria Chiara Meucci, Merte M. Hoogerduijn Strating, Steele C. Butcher, Catharina S. P. vanRijswijk, Bart Van Hoek, Victoria Delgado, Jeroen J. Bax, Maarten E. Tushuizen, Nina Ajmone Marsan
Published 2022-11-01
Article -
4
Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response... by Michelle D. van den Beukel, Anna E. C. Stoelinga, Adriaan J. van der Meer, Stef van der Meulen, Lu Zhang, Maarten E. Tushuizen, Bart van Hoek, Leendert A. Trouw
Published 2023-10-01
Article -
5
Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment by Michelle D. van den Beukel, Anna E. C. Stoelinga, Adriaan J. van der Meer, Stef van der Meulen, Lu Zhang, Maarten E. Tushuizen, Bart van Hoek, Leendert A. Trouw
Published 2023-07-01
Article -
6
Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses by Jan C. Kamp, Naomi N. Kappe, Carlos Fernández Moro, Jan Fuge, Mark P. Kuehnel, Sabine Wrenger, Tobias Welte, Bart van Hoek, Danny D. Jonigk, Padmini P. S. J. Khedoe, Pavel Strnad, Mikael Björnstedt, Jan Stolk, Sabina Janciauskiene, Antal Nemeth
Published 2023-01-01
Article -
7
The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030 by Marleen van Dijk, Sylvia M. Brakenhoff, Cas J. Isfordink, Wei-Han Cheng, Hans Blokzijl, Greet Boland, Anthonius S. M. Dofferhoff, Bart van Hoek, Cees van Nieuwkoop, Milan J. Sonneveld, Marc van der Valk, Joost P. H. Drenth, Robert J. de Knegt
Published 2021-09-01
Article -
8
Modifying Tacrolimus-related Toxicity After Liver Transplantation Comparing Life Cycle Pharma Tacrolimus Versus Extended-released Tacrolimus: A Multicenter, Randomized Controlled T... by Midas B. Mulder, PharmD, Bart van Hoek, MD, PhD, Wojtek G. Polak, MD, PhD, Ian P.J. Alwayn, MD, PhD, Brenda C.M. de Winter, PharmD, PhD, Sarwa Darwish Murad, MD, PhD, Elke Verhey-Hart, BSc, Lara Elshove, MSc, Nicole S. Erler, Dipl-Stat, PhD, Dennis A. Hesselink, MD, PhD, Caroline M. den Hoed, MD, PhD, Herold J. Metselaar, MD, PhD
Published 2024-04-01
Article -
9
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multi... by Anna E. C. Stoelinga, Maarten E. Tushuizen, Wilbert B. van den Hout, Mar D. M. Rodriguez Girondo, Elsemieke S. de Vries, Amar D. Levens, Dirk-Jan A. R. Moes, Tom J. G. Gevers, Suzanne van der Meer, Hans T. Brouwer, Hendrik J. M. de Jonge, Ynte S. de Boer, Ulrich H. W. Beuers, Adriaan J. van der Meer, Aad P. van den Berg, Maureen M. J. Guichelaar, Joost P. H. Drenth, Bart van Hoek, on behalf of the Dutch Autoimmune Hepatitis Group
Published 2024-01-01
Article